|
2024
|
Invention
|
Engineered and fully-functional customized glycoproteins.
Described herein are compositions and ... |
|
2021
|
Invention
|
Methods of producing glycosylated proteins.
Described herein are methods of producing glycosylat... |
|
|
Invention
|
Fab sialylation of antibodies.
The present disclosure provides monoclonal antibodies (e.g., anti... |
|
|
Invention
|
Fab sialylation of antibodies. The present disclosure provides monoclonal antibodies (e.g., anti-... |
|
|
Invention
|
Glycoengineering using leishmania cells.
The present application relates to Leishmania cells gen... |
|
|
Invention
|
Engineered leishmania cells.
The present application relates to a method of recombinantly engine... |
|
|
Invention
|
Glycoengineering using leishmania cells. The present application relates to Leishmania cells gene... |
|
|
Invention
|
Glycoengineering using leishmania cells. LeishmaniaLeishmaniaLeishmaniaLeishmaniaLeishmania cell ... |
|
|
Invention
|
Engineered leishmania cells. LeishmaniaLeishmaniaLeishmaniaLeishmania cell described herein and p... |
|
|
Invention
|
Engineered leishmania cells. The present application relates to a method of recombinantly enginee... |
|
2019
|
Invention
|
Glycoengineered monoclonal antibody. in vivo ex vivoex vivo mechanistic assays, in particular by ... |
|
2018
|
Invention
|
Engineered and fully-functional customized glycoproteins. Described herein are compositions and m... |
|
2017
|
G/S
|
Pharmaceutical products for the treatment of any disease or conditions to be treated by means of ... |
|
|
G/S
|
Pharmaceutical products; all the aforesaid goods of Swiss
origin. Packaging; packages, boxes; pr... |
|
2016
|
Invention
|
Methods of producing glycosylated proteins. Described herein are methods of producing glycosylate... |
|
|
G/S
|
Pharmaceutical products, namely, human vaccines, vaccine adjuvants, veterinary vaccines and thera... |
|
|
G/S
|
Pharmaceutical products. Printed matter, pamphlets, manuals, leaflets, packaging; boxes; promotio... |
